149 related articles for article (PubMed ID: 8552984)
1. Engraftment and humoral immunity in SCID and RAG-2-deficient mice transplanted with human peripheral blood lymphocytes.
Steinsvik TE; Gaarder PI; Aaberge IS; Løvik
Scand J Immunol; 1995 Dec; 42(6):607-16. PubMed ID: 8552984
[TBL] [Abstract][Full Text] [Related]
2. Human antibody response to a pneumococcal vaccine in SCID-PBL-hu mice and simultaneously vaccinated human cell donors.
Aaberge IS; Steinsvik TE; Groeng EC; Leikvold RB; Løvik M
Clin Exp Immunol; 1996 Jul; 105(1):12-7. PubMed ID: 8697618
[TBL] [Abstract][Full Text] [Related]
3. SCID-Hu mice immunized with a pneumococcal vaccine produce specific human antibodies and show increased resistance to infection.
Aaberge IS; Michaelsen TE; Rolstad AK; Groeng EC; Solberg P; Løvik M
Infect Immun; 1992 Oct; 60(10):4146-53. PubMed ID: 1398925
[TBL] [Abstract][Full Text] [Related]
4. Human peripheral blood lymphocyte severe combined immunodeficiency (hu-PBL SCID) models of toxoplasmosis.
Beaman MH; Remington JS; Meyer DJ
Immunol Cell Biol; 2000 Dec; 78(6):608-15. PubMed ID: 11114971
[TBL] [Abstract][Full Text] [Related]
5. Specific antibody production to a recall or a neoantigen by SCID mice reconstituted with human peripheral blood lymphocytes.
Nonoyama S; Smith FO; Ochs HD
J Immunol; 1993 Oct; 151(7):3894-901. PubMed ID: 8376809
[TBL] [Abstract][Full Text] [Related]
6. Total and birch pollen-specific human IgE in mice with severe combined immunodeficiency transplanted with human peripheral blood lymphocytes: donor dependence, seasonal variation and in vivo half-life.
Steinsvik TE; Aaberge IS; Gaarder PI; Bjønness U; Løvik M
Int Arch Allergy Immunol; 1997 Feb; 112(2):175-83. PubMed ID: 9030099
[TBL] [Abstract][Full Text] [Related]
7. The fate of human peripheral blood lymphocytes after transplantation into SCID mice.
Martino G; Anastasi J; Feng J; Mc Shan C; DeGroot L; Quintans J; Grimaldi LM
Eur J Immunol; 1993 May; 23(5):1023-8. PubMed ID: 8477797
[TBL] [Abstract][Full Text] [Related]
8. Role of interleukin-4 in human immunoglobulin E formation in hu-PBL-SCID mice.
Spiegelberg HL; Beck L; Kocher HP; Fanslow WC; Lucas AH
J Clin Invest; 1994 Feb; 93(2):711-7. PubMed ID: 8113405
[TBL] [Abstract][Full Text] [Related]
9. Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies.
Williams SS; Umemoto T; Kida H; Repasky EA; Bankert RB
J Immunol; 1992 Oct; 149(8):2830-6. PubMed ID: 1401915
[TBL] [Abstract][Full Text] [Related]
10. The use of the hu-PBL-SCID mouse model to study lymphocyte homing and responsiveness to recall antigens.
Lue C; Kiyono H; Fujihashi K; McGhee JR; Mestecky J
Reg Immunol; 1992; 4(2):86-90. PubMed ID: 1503891
[TBL] [Abstract][Full Text] [Related]
11. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
[TBL] [Abstract][Full Text] [Related]
12. Human primary immune response in SCID mice engrafted with human peripheral blood lymphocytes.
Sandhu J; Shpitz B; Gallinger S; Hozumi N
J Immunol; 1994 Apr; 152(8):3806-13. PubMed ID: 8144950
[TBL] [Abstract][Full Text] [Related]
13. Human peripheral blood leukocyte-reconstituted severe combined immunodeficient mouse: analysis of the human immune response against porcine islet transplantation.
Shiroki R; Naziruddin B; Shishido S; Duffy BF; Howard T; Mohanakumar T
Transplantation; 1997 Mar; 63(6):818-23. PubMed ID: 9089220
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal macrophages play an important role in eliminating human cells from severe combined immunodeficient mice transplanted with human peripheral blood lymphocytes.
Shibata S; Asano T; Noguchi A; Naito M; Ogura A; Doi K
Immunology; 1998 Apr; 93(4):524-32. PubMed ID: 9659225
[TBL] [Abstract][Full Text] [Related]
15. Development of human lymphocyte-engrafted SCID mice as a model for immunotoxicity assessment.
Pollock PL; Germolec DR; Comment CE; Rosenthal GJ; Luster MI
Fundam Appl Toxicol; 1994 Jan; 22(1):130-8. PubMed ID: 8125206
[TBL] [Abstract][Full Text] [Related]
16. Regulation of human IgE response in hu-PBL-SCID mice.
Kilchherr E; Mandak V; Wagner K; Heusser CH
Cell Immunol; 1993 Oct; 151(2):241-56. PubMed ID: 8402934
[TBL] [Abstract][Full Text] [Related]
17. Long term substitution and specific immune responses after transfer of bovine peripheral blood lymphocytes into severe combined immunodeficient mice.
Hölscher C; Hasch G; Joswig N; Stauffer U; Müller U; Mossmann H
Vet Immunol Immunopathol; 1999 Sep; 70(1-2):67-83. PubMed ID: 10507288
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a cervical cancer model via inoculating SiHa Cells into humanized severe combined immunodeficient mice.
Ye F; Chen H; Liang Z; Lu W; Cheng Q; Xie X
Eur J Gynaecol Oncol; 2006; 27(6):566-72. PubMed ID: 17290584
[TBL] [Abstract][Full Text] [Related]
19. Evidence for restricted diversity of antigen-specific human antibodies in immunized hu-PBL-SCID mice.
Bazin R; Chevrier MC; Delage R; Lemieux R
Hum Antibodies Hybridomas; 1996; 7(3):129-34. PubMed ID: 9057061
[TBL] [Abstract][Full Text] [Related]
20. Limitation of Hu-PBL-scid mouse model in direct application to immunotoxicity assessment.
Kim HM; Han SB; Hong DH; Yoo BS; Oh GT
J Pharmacol Toxicol Methods; 1997 Mar; 37(2):83-9. PubMed ID: 9174983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
